Randomized Trialhigh evidence
In elective cardiac surgery, perioperative dapagliflozin reduced acute kidney injury vs. placebo at 7 d.
Annals of internal medicine·November 3, 2026·PMID 42970797
Why it mattersAcute kidney injury is a common and serious complication after cardiac surgery, associated with worse outcomes. An SGLT2 inhibitor that reduces this risk could improve perioperative management.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled